Cancer and Leukemia Group B

描述(由申请人提供)：此UL0申请是为了支持通过维克森林大学医学院(WFUSM)及其附属成员进行的CALGB合作小组临床试验。45年来，WFUSM一直被授予CALGB U10补助金(CA03927)，作为对数据管理基础设施的关键支持，与我们附属成员所需的行政互动，以及对CALGB的科学和行政贡献的支持。除了对主要成员的支持外，这笔U10助学金还支持我们目前的两个附属成员--北卡罗来纳州格林维尔的东卡罗来纳大学和北卡罗来纳州索尔兹伯里的卡罗莱纳肿瘤学协会--的活动监督。这项赠款申请的具体目标是： *增加我们对疾病和医疗委员会活动的科学贡献 *通过在维克森林大学综合癌症中心开发可开发为CALGB方案的试点数据，加强我们临床研究人员的参与 *扩大维克森林大学综合癌症中心的附属网络，以便通过访问CALGB癌症临床试验改善对癌症患者的护理 *提供临床试验机制，让少数族裔人士可参与临床试验；提高他们参与临床试验研究的比例；并制订具体策略，以解决在临床研究研究中招募和保留少数族裔人士的区域性障碍 *继续以资助预防会员中心的身份参与

DESCRIPTION (provided by applicant): This Ul0 application is in support of the CALGB Cooperative Group Clinical Trials conducted through the Wake Forest University School of Medicine (WFUSM) and its affiliate Members. WFUSM has been continuously awarded a CALGB U10 Grant for 45 years (CA03927) as the key support of the infrastructure for data management, the required administrative interactions with our Affiliate Members, and for the support of scientific and administrative contributions to CALGB. In addition to support for the Main Member, this U10 Grant supports the oversight of activity at our two current Affiliate Members, East Carolina University, Greenville, North Carolina and Carolina Oncology Associates of Salisbury, Salisbury, North Carolina. The specific aims of this grant application are: * To increase our scientific contributions to Disease and Modality Committee activities * To enhance the participation of our clinical research investigators through the development of pilot data at the Comprehensive Cancer Center of Wake Forest University that can be developed into CALGB protocols * To expand the Affiliate Network of the Comprehensive Cancer Center of Wake Forest University in order to provide improved care of the cancer patient through access to CALGB Cancer Clinical Trials * To provide a clinical trials mechanism by which minority populations can accrue to clinical trails; to improve their proportional participation in clinical trials research; and to develop specific strategies to address regional barriers to minority recruitment and retention in clinical research studies * To continue our participation as a funded Prevention Member Center